Dose Administration Aid Patient Detect Service
|
|
- Owen Lamb
- 5 years ago
- Views:
Transcription
1 Dose Administration Aid Patient Detect Service Protocol October 2015 Version 1.3 Table of Contents Executive Summary... 1 Program objective... 1 Patient qualification... 2 Clinical Service... 2 Reporting/Claiming... 2 Software Information... 3 Program Qualification and Notification... 3 Reporting/Claiming... 3 Patient Decline... 4 Staff roles... 4 Clinical Service Information... 4 Resources... 4 Appendix A: How to report a problem with a medicine or medical device to the Therapeutic Goods Administration... 5 Executive Summary Program objective The GuildCare Dose Administration Aid (DAA) Patient Detect Service program is designed to help pharmacists:
2 Identify patients who may benefit from having their medicines packed in a DAA, and Generate a personalised patient engagement handout detailing the benefits of the service. Patient qualification GuildCare software will produce a pop-up notification to prompt at the point of dispense for patients on five or more packable medications. Pharmacists can also initiate documentation [ad-hoc] of a service through the GuildCare DAA Patient Detect Service program. Clinical Service The pharmacist will conduct the service in accordance with relevant guidelines and other relevant industry protocols. As part of delivering the DAA Patient Detect Service, Pharmacists are under obligation to adhere to the relevant professional practice standards. This includes but is not limited to applying professional judgement to identify, record and report potential or actual medication related problems that are likely to be clinically significant for the patient (e.g. interactions, contraindications, incompatibilities, allergies, adverse drug reactions) to the patient s Medical Practitioner, the Therapeutic Goods Administration and any other relevant entity. (For further information see Appendix A: How to report a problem with a medicine or medical device to the Therapeutic Goods Administration). Reporting/Claiming Reporting for the GuildCare DAA Patient Detect Service can be found under the Services Summary Report. This report is accessed via the GuildCare Documentation tab under Reports'. DAA Patient Detect Service Version 1.3 October 2015 GuildLink Pty Ltd 2
3 Software Information Program Qualification and Notification Two ways: 1. The patient requests or pharmacy invites patient as required [Ad-hoc] e.g. Mrs Jones is taking 6 different tablets and often forgets when she needs to take each one. Pharmacy invites Mrs Jones to consider a DAA to help manage her medications and provides her with more information about the service. 2. The pharmacy is prompted by software to invite patients five or more packable medications [Prompted] e.g. Mr Smith has five or more packable medications in his dispense history; pharmacy staff are notified by a GuildCare pop-up prompt upon dispense. Ad-hoc If a patient enquires about DAA services or a pharmacist recommends this, the patient can be enrolled in the program Ad-hoc at any time. If a patient is not already present in the Patients list in the GuildCare software, click Add Patient and follow the on-screen prompts. From the Current Patient tab, Click Add and select Dose Administration Aid from the Professional Service drop-down list then click Enrol. Prompted The GuildCare software will also identify patients by analysing their dispense history. It analyses all available dispense records of your pharmacy only. A pop-up notification will prompt staff at the point of dispense for patients with five or more packable medications based on a list maintained by GuildCare. Reporting/Claiming Reporting for the GuildCare DAA Patient Detect Service can be found under the Services Summary Report. This report is accessed via the GuildCare Documentation tab under Reports'. The GuildCare DAA Patient Detect Service program does not directly attract funding under. Pharmacies must use their dispense software or DAA packing software (e.g. from their packing provider) to accurately report on the number of community patients that use the pharmacy s packing service. Claiming for DAA Services conducted and recorded in accordance with the requirements must be done quarterly through the web portal. Eligible Claiming Periods 1 January to 31 March (approx. 13 weeks) 14 April 1 April to 31 May (approx. 9 weeks) 14 June Claim Due Date 1 June to 30 September (approx. 17 weeks) 14 October 1 October to 31 December (approx. 13 weeks) 14 January DAA Patient Detect Service Version 1.3 October 2015 GuildLink Pty Ltd 3
4 Patient Decline If the pharmacist does not wish to continue after a DAA Patient Detect Service case has been created, the pharmacist should select Declined as the case status. Staff roles To allow for appropriate workflow and consistent delivery of DAA Patient Detect Services, it is advised to inform and where appropriate train staff members about the service the pharmacy is providing patients and their role in the process. Clinical Service Information It is likely that each patient s drug related needs will be different. The pharmacists must apply their clinical knowledge to the patient s situation and provide appropriate advice, information and recommendation(s) as they see fit. The skills and knowledge required to conduct DAA packing services are developed through training external to GuildCare (see Resources for more information). The GuildCare DAA Patient Detect Service program is designed to help pharmacists identify patients who may benefit from having their medications packed, and generate a personalised patient engagement handout. The pharmacist conducts the following as part of each service: Complete the patient engagement handout from the Documentation tab of the GuildCare DAA Patient Detect Service program Record any additional information which may be of benefit to the patient in relation to the pharmacy s DAA service. Suggested information includes: o Cost of the service on top of their usual medicines costs o That other customers benefit from having their medicines packed o That the pharmacy can show them a sample of what the pack looks like and how to use it Provide comments and any other professional Pharmacist Recommendations Click Print and provide the engagement handout to the patient Inform the patient of how the pharmacy s service works Record the outcome after engaging with the patient Resources Title Dose Administration Aids PPI Programmes Specific Guidelines Calculating your DAA Claim - worksheet Standard and Guidelines for Pharmacists providing a DAA Service QCPP T3B Dose Administration Aids Checklist Author/Source Pharmaceutical Society of Australia QCPP Pharmacy Guild of Australia DAA Patient Detect Service Version 1.3 October 2015 GuildLink Pty Ltd 4
5 Appendix A: How to report a problem with a medicine or medical device to the Therapeutic Goods Administration Information for health professionals Source: The Therapeutic Goods Administration (TGA) is a division of the Australian Government Department of Health and Ageing and is responsible for regulating medicines and medical devices. The work of the TGA is based on applying scientific and clinical expertise to ensure that the benefits to consumers outweigh any risks associated with the use of medicines and medical devices. The TGA relies on the public, healthcare professionals and industry to report problems with medicines or medical devices so that the TGA can identify and respond to safety matters. When to report If a patient has experienced or you suspect they may be experiencing an adverse event relating to a medicine or medical device, report the adverse event to the TGA. Suspected adverse events should be reported the first time they occur, as well as any time they occur thereafter. What to report Please report any suspected adverse event that your patient(s) may be experiencing, in particular: serious reactions (e.g. resulting in hospitalisation) unexpected reactions (reactions not consistent with consumer medicine information or labelling) all suspected reactions to medicines recently introduced in Australia all suspected adverse events that may be caused by combinations of medicines (drug interactions) faults with medical devices resulting in an adverse event (keep the faulty equipment until you have contacted the TGA). What to include in your report In your report include (if applicable): basic details of the patient experiencing the adverse event initials, date of birth, gender details of the adverse event or reaction date it occurred, symptoms experienced (including duration), description of device fault resulting in adverse event, treatment required and outcome (if known) details of the medicine or device involved name, description, dose, for a complementary medicine include AUST L number details of any other medicine(s) the patient experiencing the adverse event may be taking. Report a medicine or medical device adverse event to the TGA How to report Report a suspected adverse event directly to the TGA using: GuildCare s Adverse Events Recording module, sent electronically via a web service portal direct to the TGA the TGA website - Alternatively: Medicines Phone: or adr.reports@tga.gov.au Medical devices Phone: iris@tga.gov.au DAA Patient Detect Service Version 1.3 October 2015 GuildLink Pty Ltd 5
Table of Contents Service Information... 2
Protocol October 2015 Version 1.1 Table of Contents Service Information... 2 Service objective... 2 Clinical service overview... 2 Screening... 2 Documentation... 3 Staff Roles... 3 Facilities to support
More informationTable of Contents Service Information... 2
Protocol October 2015 Version 1.0 Table of Contents Service Information... 2 Service objective... 2 Clinical service overview... 2 Documentation... 3 Staff Roles... 3 Facilities to support the program...
More informationVaccination Recording
Protocol January 2017 Version 1.6 Table of Contents Service Information... 2 Service objective... 2 Clinical service overview... 2 Documentation... 3 Staff Roles... 4 Facilities to support the program...
More informationThis document provides information on conducting the Perindopril New To Therapy Program using GuildCare software.
Perindopril New To Therapy Program PROTOCOL This document provides information on conducting the Perindopril New To Therapy Program using GuildCare software. April 2015 Table of Contents Executive Summary...
More informationNew To Therapy GuildCare Program
Spiriva/Spiolto Respimat (Tiotropium/Tiotropium and Olodaterol) New To Therapy GuildCare Program PROTOCOL This document provides information on conducting the Spiriva/Spiolto Respimat New To Therapy Program
More informationMedication Management Policy and Procedures
POLICY STATEMENT This policy establishes guidelines for ensuring safe and correct management of client medications in accordance with legislative and regulatory requirements and professional practice competency
More informationDispensing Medications Practice Standard
October 2013 Updated December 8, 2016 s set out baseline requirements for specific aspects of Registered Psychiatric Nurses practice. They interact with other requirements such as the Code of Ethics, the
More informationColorado Board of Pharmacy Rules pertaining to Collaborative Practice Agreements
6.00.00 PHARMACEUTICAL CARE, DRUG THERAPY MANAGEMENT AND PRACTICE BY PROTOCOL. 6.00.10 Definitions. a. "Pharmaceutical care" means the provision of drug therapy and other pharmaceutical patient care services
More informationStandards for the Provision of Pharmacy
Standards for the Provision of Pharmacy Medicines and Pharmacist Only Medicines in Community Pharmacy Revised, November 2005 2006 Version 3 Professional Practice Standards Pharmaceutical Society of Australia
More informationPractice Tools for Safe Drug Therapy
Practice Tools for Safe Drug Therapy Practice Tools for Safe Drug Therapy Pharmacists and pharmacy technicians make sure the right person gets the right dose of the right drug at the right time and takes
More informationSELF - ADMINISTRATION OF MEDICINES AND ADMINISTRATION OF MEDICINES SUPPORTED BY FAMILY/INFORMAL CARERS OF PATIENTS IN COMMUNITY NURSING
CLINICAL PROTOCOL SELF - ADMINISTRATION OF MEDICINES AND ADMINISTRATION OF MEDICINES SUPPORTED BY FAMILY/INFORMAL CARERS OF PATIENTS IN COMMUNITY NURSING RATIONALE Medication errors can cause unnecessary
More information4. Hospital and community pharmacies
4. Hospital and community pharmacies As FIP is the international professional organisation of pharmacists, this paper emphasises the role of the pharmacist in ensuring and increasing patient safety. The
More informationSection Title. Prescribing competency framework Catherine Picton, Lead author
Prescribing competency framework Catherine Picton, Lead author What is in this presentation Context Uses of the competency framework Scope of the updated prescribing competency framework Introduction to
More informationScotia College of Pharmacists Standards of Practice. Practice Directive Prescribing of Drugs by Pharmacists
Scotia College of Pharmacists Standards of Practice Practice Directive Prescribing of Drugs by Pharmacists September 2014 ACKNOWLEDGEMENTS This Practice Directives document has been developed by the Prince
More informationNon-Medical Prescribing Passport. Reflective Log And Information
Non-Medical Prescribing Passport Reflective Log And Information Non-Medical Prescribing Continued Profession Development Log NMPs must refer to their regulatory bodies requirements for maintaining and
More informationADMINISTRATION OF ORAL MEDICATIONS IN THE COMMUNITY BY ATTENDANT CARE SUPPORT WORKERS
Title Purpose ADMINISTRATION OF ORAL MEDICATIONS IN THE COMMUNITY BY ATTENDANT CARE SUPPORT WORKERS This guideline is to assist: Attendant care service providers (organisations and individuals), participants,
More information5. returning the medication container to proper secured storage; and
111-8-63-.20 Medications. (1) Self-Administration of Medications. Residents who have the cognitive and functional capacities to engage in the self-administration of medications safely and independently
More informationSupply of Fusidic Acid Cream 2% by Community Pharmacists for the treatment of impetigo in patients 2 years of age and over.
Supply of Fusidic Acid Cream 2% by Community Pharmacists for the treatment of impetigo in patients 2 years of age and over. November 2017 Review Nov 2019 Signatures of those developing the Patient Group
More informationNEW JERSEY. Downloaded January 2011
NEW JERSEY Downloaded January 2011 SUBCHAPTER 29. MANDATORY PHARMACY 8:39 29.1 Mandatory pharmacy organization (a) A facility shall have a consultant pharmacist and either a provider pharmacist or, if
More information2. Short term prescription medication and drugs (administered for less than two weeks):
Medication Administration Procedure This is a companion document with Policy # 516 Student Medication To access the policy: click on Policies (under the District Information heading) The Licensed School
More informationLicensed Pharmacy Technicians Scope of Practice
Licensed s Scope of Practice Adapted from: Request for Regulation of s Approved by Council April 24, 2015 DEFINITIONS In this policy: Act means The Pharmacy and Pharmacy Disciplines Act means an unregulated
More informationPHARMACIST INDEPENDENT PRESCRIBING MEDICAL PRACTITIONER S HANDBOOK
PHARMACIST INDEPENDENT PRESCRIBING MEDICAL PRACTITIONER S HANDBOOK 0 CONTENTS Course Description Period of Learning in Practice Summary of Competencies Guide to Assessing Competencies Page 2 3 10 14 Course
More informationOverview of e-portfolio Learning Activities for Part III Community Pharmacy Placements
Overview of e-portfolio Learning Activities for Part III Community Pharmacy Placements Placement Module 2 & 3 The following sections must be completed for Placement. Pre-placement Preparation My Glossary
More informationTemplate (to be adapted by care home) Medication to be administered on a PRN (when required) basis in a care home environment
Template (to be adapted by care home) Medication to be administered on a PRN (when required) basis in a care home environment The PRN Purpose & Outcome Protocol (PRN POP) Background The term PRN (from
More informationDISPENSING BY REGISTERED NURSES (RNs) EMPLOYED WITHIN REGIONAL HEALTH AUTHORITIES (RHAs)
2017 DISPENSING BY REGISTERED NURSES (RNs) EMPLOYED WITHIN REGIONAL HEALTH AUTHORITIES (RHAs) This Interpretive Document was approved by ARNNL Council in 2017 and replaces Dispensing by Registered Nurses
More informationProfessional Student Outcomes (PSOs) - the academic knowledge, skills, and attitudes that a pharmacy graduate should possess.
Professional Student Outcomes (PSOs) - the academic knowledge, skills, and attitudes that a pharmacy graduate should possess. Number Outcome SBA SBA-1 SBA-1.1 SBA-1.2 SBA-1.3 SBA-1.4 SBA-1.5 SBA-1.6 SBA-1.7
More informationCommunity Nurse Prescribing (V100) Portfolio of Evidence
` School of Health and Human Sciences Community Nurse Prescribing (V100) Portfolio of Evidence Start date: September 2016 Student Name: Student Number:. Practice Mentor:.. Personal Tutor:... Submission
More informationPROMISe Phase Two Final Report to the Pharmacy Guild of Australia (RFT , Evaluation of Clinical Interventions in Community Pharmacies)
PROMISe Phase Two Final Report to the Pharmacy Guild of Australia (RFT 2003-2, Evaluation of Clinical Interventions in Community Pharmacies) This research was funded by the Australian Government Department
More informationPOLICY AND PROCEDURE DEPARTMENT: Pharmacy Operations
PAGE: 1 of 5 SCOPE: Centene Corporate Pharmacy Solutions, Centene Corporate Pharmacy and Therapeutics Committee, Health Plan Pharmacy Departments, Health Plan Pharmacy and Therapeutics Committees, Pharmacy
More informationTransfer of Care (ToC) service Frequently asked questions
Transfer of Care (ToC) service Frequently asked questions 1) What is the Transfer of Care Service? The Transfer of Care service is a new service which aims to ensure patients receive appropriate support
More informationPractice Handbook for Designated Medical Practitioners
Faculty of Health and Wellbeing Non Medical Prescribing Level 6 / Level 7 Practice Handbook for Designated Medical Practitioners Contents Introduction 3 Aims of the course 4 Learning Outcomes 4 The Role
More informationGuidelines for Managing Pharmacy Systems for Quality and Safety November 2002
November 2002 Guidelines for Managing Pharmacy Systems for Quality and Safety Background The Australian Council for Safety and Quality in Health Care (ACSQHC) was established by Australian Health Ministers
More informationCLINICAL AUDIT. The Safe and Effective Use of Warfarin
CLINICAL AUDIT The Safe and Effective Use of Warfarin Valid to May 2019 bpac nz better medicin e Background Warfarin is the medicine most frequently associated with adverse drug reactions in New Zealand.
More informationChapter 13. Documenting Clinical Activities
Chapter 13. Documenting Clinical Activities INTRODUCTION Documenting clinical activities is required for one or more of the following: clinical care of individual patients -sharing information with other
More informationOptimiseRx Prescribers User Guide for SystmOne
PRODUCT OVERVIEW: OptimiseRx OptimiseRx Fully integrated with the patient record to enable the delivery of prescribing best practice and to optimise cost savings. 2016 First Databank Europe Ltd. A subsidiary
More informationTitle Administration of Oral Medication in the Community by Support Workers Purpose Background dignity of risk Scope Disclaimer Copyright ACIA 2017
Title Purpose Background Administration of Oral Medication in the Community by Support Workers This guideline is to assist service providers (organisations and individuals), Participants, stakeholders,
More informationPOLICY AND PROCEDURE DEPARTMENT: Pharmacy Operations
PAGE: 1 of 6 SCOPE: Centene Corporate Pharmacy Department, Centene Corporate Pharmacy and Therapeutics Committee, Health Plan Pharmacy Departments, Health Plan Pharmacy and Therapeutics Committees, and
More informationBar Code Medication Administration and MAR Resource Manual
Bar Code Medication Administration and MAR Resource Manual Administering Medications Administering Meds using CareMobile (PDA)... 2 Viewing Allergies in CareMobile... 8 Determining Which Meds to Give When...
More informationAPPENDIX 8-2 CHECKLISTS TO ASSIST IN PREVENTING MEDICATION ERRORS
APPENDIX 8-2 CHECKLISTS TO ASSIST IN PREVENTING MEDICATION ERRORS Use the following checklists in the appropriate areas of your office, facility or practice to assist in preventing medications errors:
More informationSelf-assessment worksheet for the Professional Practice Standards version 4
Self-assessment worksheet for the Professional Practice Standards version The following self-assessment worksheet and the Professional Practice Standards version are intended to serve as a guide to achieving
More informationWhat does governance look like in homecare?
What does governance look like in homecare? Dr David Cousins PhD FRPharmS Head of Pa)ent Safety, Healthcare at Home Ltd This Satellite is sponsored by Healthcare at Home Ltd Definitions Clinical governance
More informationCOMMUNITY PHARMACY MINOR AILMENTS SERVICE
COMMUNITY PHARMACY MINOR AILMENTS SERVICE SUPPORTING SELF-CARE OCTOBER 2010 CONTENTS Index Page No 1 Introduction 3 2 Service Specification 4 3 Consultation Procedure 7 4 Re-ordering Documentation 10 Appendices
More informationMedicines Reconciliation Standard Operating Procedures
Creator Sam Carvell, Amber Wynne, Sue Coppack Version 1 Review Date Medicines Reconciliation Standard Operating Procedures Purpose of SOP This standard operating procedure (SOP) provides a framework for
More informationAPPROACHES TO ENHANCING THE QUALITY OF DRUG THERAPY A JOINT STATEMENT BY THE CMA ANDTHE CANADIAN PHARMACEUTICAL ASSOCIATION
APPROACHES TO ENHANCING THE QUALITY OF DRUG THERAPY A JOINT STATEMENT BY THE CMA ANDTHE CANADIAN PHARMACEUTICAL ASSOCIATION This joint statement was developed by the CMA and the Canadian Pharmaceutical
More informationMeaningful Use Hello Health v7 Guide for Eligible Professionals. Stage 1
Meaningful Use Hello Health v7 Guide for Eligible Professionals Stage 1 Table of Contents Introduction 3 Meaningful Use 3 Terminology 5 Computerized Provider Order Entry (CPOE) for Medication Orders [Core]
More information1. PURPOSE 2. SCOPE 3. RESPONSIBILITIES
1. PURPOSE The purpose of this standard operating procedure (SOP) is to inform all Alexion personnel, and applicable service providers who become aware of a Pharmacovigilance (PV) Event of their responsibility
More informationThe CMS State Operations Manual Overview and Changes
The CMS State Operations Manual Overview and Changes Omnicare, Inc. Page 1 Overview of the CMS State Operations Manual Executive Summary Historical Perspective The Requirements Pharmacy Services Labeling
More informationPharmacovigilance Office of Product Review
Pharmacovigilance Office of Product Review Dr Jane Cook Office Head Office of Product Review, Monitoring & Compliance Group, TGA 7/10/2011 Overview of talk Overview Post TGA 21 and OPR New Guidelines Key
More informationMy Health Record. Katrina Otto Trainer, Australian Digital Health Agency Practice Management Consultant & Principal - Train IT Medical
My Health Record Katrina Otto Trainer, Australian Digital Health Agency Practice Management Consultant & Principal - Train IT Medical What could you find in someone s My Health Record? Uploaded by Healthcare
More informationAdministration of Oral Prescription Medication Procedure Page 1 of 6
Page 1 of 6 RATIONALE: Hamilton-Wentworth District School Board is committed to ensuring the provision of plans, programs, and/or services that will enable students with health or medical needs to attend
More informationMANAGEMENT AND ADMINISTRATION OF MEDICATION. 1. The Scope and Role of the Senior Registered Nurse (SRN)
Policy 1 MANAGEMENT AND ADMINISTRATION OF MEDICATION 1. The Scope and Role of the Senior Registered Nurse (SRN) The Senior Registered Nurse is responsible for overseeing medication management in the facility.
More informationPG Certificate / PG Diploma / MSc in Clinical Pharmacy
PG Certificate / PG Diploma / MSc in Clinical Pharmacy 2008/09 Programme Course manager: Brian McCaw (b.mccaw@qub.ac.uk) Distance Learning Centre The School of Pharmacy Queen's University Belfast PG Certificate
More informationSupply of Fusidic acid 2% cream for impetigo by Community Pharmacists Protocol Number 472 version 1
Supply of Fusidic acid 2% cream for impetigo by Community Pharmacists Protocol Number 472 Date protocol prepared: December 2015 Date protocol due for review: December 2017 This patient group direction
More informationNova Scotia Drug Information System
Nova Scotia Drug Information System INTRODUCTION Presentation Details: Slides: 21 Duration: 00:22:44 Filename: Module1.Introduction.ppt Presenter Details: Slide 1 Nova Scotia Drug Information System Duration:
More informationHow to Report Medication Safety Incidents from a GP Practice on the National Reporting and Learning System (NRLS)
pecialist Pharmacy ervice Medicines Use and afety How to Report Medication afety Incidents from a GP Practice on the National Reporting and Learning ystem (NRL) This document provides a quick explanation
More informationFundamentals of Self-Limiting Conditions Prescribing for Manitoba Pharmacists. Ronald F. Guse Registrar College of Pharmacists of Manitoba (CPhM)
Fundamentals of Self-Limiting Conditions Prescribing for Manitoba Pharmacists Ronald F. Guse Registrar College of Pharmacists of Manitoba (CPhM) 1 Learning Objectives Upon successful completion of this
More informationGuidelines on the Keeping of Records in Respect of Medicinal Products when Conducting a Retail Pharmacy Business
Guidelines on the Keeping of Records in Respect of Medicinal Products when Conducting a Retail Pharmacy Business to facilitate compliance with Regulation 12 of the Regulation of Retail Pharmacy Businesses
More informationREVISED FIP BASEL STATEMENTS ON THE FUTURE OF HOSPITAL PHARMACY
REVISED FIP BASEL STATEMENTS ON THE FUTURE OF HOSPITAL PHARMACY Approved September 2014, Bangkok, Thailand, as revisions of the initial 2008 version. Overarching and Governance Statements 1. The overarching
More informationExpiry Date: January 2009 Template Version: Page 1 of 7
YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: Inclusion criteria: Exclusion criteria: Cautions/Need for
More informationAged residential care (ARC) Medication Chart implementation and training guide (version 1.1)
Aged residential care (ARC) Medication Chart implementation and training guide (version 1.1) May 2018 Prepared by and the Health Quality & Safety Commission Version 1, March 2018; version 1.1, May 2018
More informationDerbyshire Medicines Management on behalf of Southern Derbyshire CCG, Erewash CCG, North Derbyshire CCG & Hardwick CCG
Derbyshire Medicines Management on behalf of Southern Derbyshire CCG, Erewash CCG, rth Derbyshire CCG & Hardwick CCG CCG Position Statement on the Supply of Multi-Compartment Compliance Aids (MCAs) There
More informationAll Wales Multidisciplinary Medicines Reconciliation Policy
All Wales Multidisciplinary Medicines Reconciliation Policy June 2017 This document has been prepared by the Quality and Patient Safety Delivery Group of the All Wales Chief Pharmacists Group, with support
More informationDEPARTMENT OF HEALTH AND HUMAN SERVICES CENTERS FOR MEDICARE & MEDICAID SERVICES
Use for a resident who has potentially unnecessary medications, is prescribed psychotropic medications or has the potential for an adverse outcome to determine whether facility practices are in place to
More informationOut of hours supply of medication by nurses on the children s ward.
Out of hours supply of medication by nurses on the children s ward. Next review Page 1 of 5 Protocol: Executive Summary: Out of hours supply of medication by nurses on the children s ward. This protocol
More informationCHAPTER 9 PERFORMANCE IMPROVEMENT HOSPITAL
CHAPTER 9 PERFORMANCE IMPROVEMENT HOSPITAL PERFORMANCE IMPROVEMENT Introduction to terminology and requirements Performance Improvement Required (Board of Pharmacy CQI program, The Joint Commission, CMS
More informationSupply of Fusidic acid 2% cream for impetigo by Community Pharmacists Protocol Number 472 version 2
Supply of Fusidic acid 2% cream for impetigo by Community Pharmacists Protocol Number 472 version 2 Date protocol prepared: October 2017 Date protocol due for review: October 2019 Expiry date: October
More informationNOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.
TITLE MEDICATION ORDERS SCOPE Provincial APPROVAL AUTHORITY Clinical Operations Executive Committee SPONSOR Provincial Medication Management Committee PARENT DOCUMENT TITLE, TYPE AND NUMBER Not applicable
More informationPolicies Approved by the 2017 ASHP House of Delegates
House of Delegates Policies Approved by the 2017 ASHP House of Delegates 1701 Ensuring Patient Safety and Data Integrity During Cyber-attacks Source: Council on Pharmacy Management To advocate that healthcare
More informationQuality Care Pharmacy Program. An initiative of The Pharmacy Guild of Australia. Supporting Excellence in Pharmacy. January February 2012
Quality Care Pharmacy Program An initiative of The Pharmacy Guild of Australia Supporting Excellence in Pharmacy January February 2012 FOCUS ON THE STANDARD: SCREENING AND RISK ASSESSMENT UPDATES TO QCPP
More informationHeart. Failure. Health Program
Heart Failure Health Program Heart Failure program The Heart Failure program is designed to help people living with chronic heart failure better understand and manage their condition, with the support
More informationEthics and dispensing in pharmacy practice
V5 2017 V00.0 2012 Ethics and dispensing in pharmacy practice Course handbook RTO Provider No. 122206 Course overview Part 1 Legislation and pharmacy practice: Covers skills and knowledge required to practice
More informationExpiry Date: January 2009 Template Version: Page 1 of 7
YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: Inclusion criteria: Patients who require an antihistamine
More informationMEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL REPORTING ADVERSE DRUG REACTIONS IN SOUTH AFRICA IMPORTANT NOTE This guideline applies only to the reporting of SAEs during clinical trials. An update of the guideline for this
More informationProgram Guide for Pharmacists
Program Guide for Pharmacists Supporting Quality Use of Medicines February 2015 - Version 1 An initiative of Protocol This document provides information for the Brintellix Patient Program (Program). Detailed
More informationStandard Operating Procedure (SOP) Research and Development Office
Standard Operating Procedure (SOP) Research and Development Office Title of SOP: Delegated Responsibilities in Research Projects SOP Number: 11 Version Number: 2.0 Supercedes: 1.0 Effective date: August
More informationNova Scotia College of Pharmacists. Standards of Practice. Prescribing Drugs
Nova Scotia College of Pharmacists Standards of Practice November 2015 Acknowledgements Acknowledgements This Standards of Practice document has been developed by the Nova Scotia College of Pharmacists
More informationHospitals are excluded from participating in the PBS Co-Payment Measure.
Position Paper: Closing The Gap Pharmaceutical Benefits Schedule Co-payment Measure (CTG PBS Co-payment) Improving access to Pharmaceutical Benefits Schedule Medicines for Aboriginal and Torres Strait
More informationQUALIFICATION DETAILS
Outcome Statement QUALIFICATION DETAILS Qualification Title New Zealand Certificate in Pharmacy (Pharmacy Technician) (Level 4) Version 1 Qualification type Certificate Level 4 Credits 75 NZSCED DAS Classification
More informationMODULE 5: RECORDING & ERRORS
MODULE 5: RECORDING & ERRORS 5.1 Recording Administration Using a Medication Administration Record (MAR) Chart Care providers are responsible for maintaining an up-to-date record of medication administered.
More informationPost Market Surveillance Requirements. SAMED Regulatory Conference 2 December 2015
Post Market Surveillance Requirements SAMED Regulatory Conference 2 December 2015 Topics Surveillance & Vigilance Adverse Events Reportable Adverse Events Reporting Adverse Events Time frames Exemptions
More informationNEW STANDARD OF PRACTICE PRESCRIBING
NEW STANDARD OF PRACTICE PRESCRIBING Notice to College Members June 21, 2018 Following consultation with College Members, on June 16, 2018 Council of the College approved a new Standard of Practice on
More informationTransnational Skill Standards Pharmacy Assistant
Transnational Skill Standards Pharmacy Assistant REFERENCE ID: HSS/ Q 5401 Mapping for Pharmacy Assistant (HSS/ Q 5401) with UK SVQ level 2 Qualification Certificate in Pharmacy Service Skills Link to
More informationSafer use of anticoagulants: the NPSA patient safety alert Steve Chaplin MSc, MRPharmS
Safer use of anticoagulants: the NPSA patient safety alert Steve Chaplin MSc, MRPharmS Steve Chaplin describes the NPSA s anticoagulant patient safety alert and the measures it recommends for making the
More informationPHARMACY SERVICES/MEDICATION USE
25.01. 10 Drug Reactions & Administration Errors & Incompatibilities. Drug administration errors, adverse drug reactions and incompatibilities must be immediately reported to the attending physician and
More informationPrescription Writer/ eprescribe
Prescription Writer is an application within Acute Care that allows providers to do the following: 1. Create and maintain a list of home medications 2. Electronically transmit new prescriptions 3. Convert
More informationPATIENT GROUP DIRECTION
PATIENT GROUP DIRECTION FOR THE SUPPLY OF FUSIDIC ACID CREAM 2% FOR THE TREATMENT OF IMPETIGO BY COMMUNITY PHARMACISTS UNDER THE PHARMACY FIRST SERVICE IN NHS HIGHLAND THE COMMUNITY PHARMACIST SEEKING
More informationSocial care guideline Published: 14 March 2014 nice.org.uk/guidance/sc1
Managing medicines in care homes Social care guideline Published: 14 March 2014 nice.org.uk/guidance/sc1 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).
More informationGuidelines for pharmacists providing dose administration aid services
Guidelines for pharmacists providing dose administration aid services PSA Committed to better health Pharmaceutical Society of Australia Ltd. 2017 This publication contains material that has been provided
More informationMedicines Reconciliation: Standard Operating Procedure
Clinical Medicines Reconciliation: Standard Operating Procedure Document Control Summary Status: Version: Author/Owner/Title: Approved by: Ratified: Related Trust Strategy and/or Strategic Aims Implementation
More information247 CMR: BOARD OF REGISTRATION IN PHARMACY
247 CMR 9.00: CODE OF PROFESSIONAL CONDUCT; PROFESSIONAL STANDARDS FOR REGISTERED PHARMACISTS, PHARMACIES AND PHARMACY DEPART- MENTS Section 9.01: Code of Professional Conduct for Registered Pharmacists,
More informationVersion Number: 004 Controlled Document Sponsor: Controlled Document Lead:
Chief Investigators and Principal Investigators in Research Policy CONTROLLED DOCUMENT CATEGORY: CLASSIFICATION: PURPOSE Controlled Document Number: Policy Governance To set out the responsibilities of
More informationIsotretinoin : Review of the Pregnancy Prevention Programme
Safeguarding public health Isotretinoin : Review of the Pregnancy Prevention Programme HCP WG meeting October 2011: Dr Sarah Mee Isotretinoin: UK RMS Introduction In 2003, European referral led to introduction
More informationLESSON ASSIGNMENT. Professional References in Pharmacy.
LESSON ASSIGNMENT LESSON 1 Professional References in Pharmacy. TEXT ASSIGNMENT Paragraphs 1-1 through 1-8. LESSON OBJECTIVES 1-1. Given a description of a reference used in pharmacy and a list of pharmacy
More informationBest Practice Procedures
Best Practice Procedures FOR RESIDENTIAL AGED CARE FACILITIES 17-19 Moore Street, Leichhardt NSW 2040 P: +61 (0)2 9563 4900 I FREE CALL 1800 244 358 F: +61 (0)2 9563 4955 I FREE FAX 1800 626 739 EMAIL:
More informationInstyMeds Prescription Writer Tutorial
InstyMeds Prescription Writer Tutorial July 2014 Log in to the InstyMeds Prescription Writer tool Important messages announcing the latest enhancements and notifications are located here. 1. Type in Username
More informationDiploma In Drug & Pharmacy CURRICULUM/SYLLABUS. Course Code: 8274
Diploma In Drug & Pharmacy CURRICULUM/SYLLABUS Course Code: 8274 This program is aimed at training candidates for the job of a Working in Medical Stores or in Pharmacy Company where he/she can able to
More informationAnnexure A COMPETENCE STANDARDS FOR CPD INTRODUCTION
COMPETENCE STANDARDS FOR CPD INTRODUCTION Pharmacists in each field of practice need to accept responsibility for the selfassessment and maintenance of their competence throughout their professional lives.
More informationCoastal West Sussex Interface Prescribing Policy
Coastal West Sussex Interface Prescribing Policy Agreement between Commissioners: Coastal West Sussex CCG And Providers: Western Sussex NHS Foundation Trust (WSfT) Sussex Community NHS Trust (SCT) Sussex
More informationRESEARCH GOVERNANCE POLICY
RESEARCH GOVERNANCE POLICY DOCUMENT CONTROL: Version: V6 Ratified by: Performance and Assurance Group Date ratified: 12 November 2015 Name of originator/author: Assistant Director of Research Name of responsible
More informationManaging medicines in care homes
Managing medicines in care homes http://www.nice.org.uk/guidance/sc/sc1.jsp Published: 14 March 2014 Contents What is this guideline about and who is it for?... 5 Purpose of this guideline... 5 Audience
More information